Clinical Trial Update: Intralesional Bevacizumab Injection on Primary Pterygium [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating intralesional bevacizumab for primary pterygium is summarized as an update with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation
• Pterygium

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Khon Kaen University | Conditions: Pterygium, Inflammation | Phase 3 | Status: UNKNOWN